Carter P, Welbourne T
Department of Physiology, Louisiana State University Medical Center, Shreveport 71130, USA.
Am J Physiol. 1997 Sep;273(3 Pt 1):E521-7. doi: 10.1152/ajpendo.1997.273.3.E521.
We proposed that glutamate transport into cultured kidney cells represses cellular glutaminase activity and hence regulates glutamine utilization. To test this putative regulatory mechanism in vivo, glutamine uptake and conversion to glutamate as well as ammonium production were measured in the intact functioning rat kidney. Glutamine uptake was determined as net removal, arteriovenous concentration difference times renal plasma flow, and also as unidirectional uptake from the fractional extraction of tracer L-[14C]glutamine. Ammonium production was measured as that released into the renal vein plus that excreted, and intracellular glutamine conversion to glutamate was assessed from the rise in cortical glutamate radiolabel specific activity. Cellular glutamate content was reduced 50-60% by infusing D-aspartate (a high-affinity glutamate transporter inhibitor) over 30 min, consistent with interdiction of glutamate uptake. This reduction in the glutaminase repressor was associated with a three- to fivefold increase in glutamine uptake and intracellular conversion to glutamate and ammonium. These results are consistent with and predictable from our previous in vitro model and point to an important role for this regulatory mechanism in the intact functioning organ.
我们提出,谷氨酸转运进入培养的肾细胞会抑制细胞谷氨酰胺酶活性,从而调节谷氨酰胺的利用。为了在体内测试这种假定的调节机制,我们在完整功能的大鼠肾脏中测量了谷氨酰胺摄取、转化为谷氨酸以及铵的产生。谷氨酰胺摄取被确定为净清除率,即动静脉浓度差乘以肾血浆流量,也可通过示踪剂L-[14C]谷氨酰胺的分数提取来确定单向摄取。铵的产生通过释放到肾静脉中的量加上排泄量来测量,细胞内谷氨酰胺转化为谷氨酸则通过皮质谷氨酸放射性标记比活性的升高来评估。通过在30分钟内注入D-天冬氨酸(一种高亲和力谷氨酸转运体抑制剂),细胞内谷氨酸含量降低了50-60%,这与谷氨酸摄取的阻断一致。谷氨酰胺酶阻遏物的这种减少与谷氨酰胺摄取以及细胞内转化为谷氨酸和铵的增加三到五倍有关。这些结果与我们之前的体外模型一致且可预测,表明这种调节机制在完整功能器官中具有重要作用。